Mirum Pharmaceuticals, Inc. (MIRM)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 25.79 |
| Open | 25.81 |
| Bid | 26.20 x 100 |
| Ask | 26.30 x 100 |
| Day's Range | 25.59 - 26.44 |
| 52 Week Range | 23.14 - 35.56 |
| Volume | |
| Avg. Volume | 481,840 |
| Market Cap | 1.236B |
| Beta (5Y Monthly) | 1.13 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -3.80 |
| Earnings Date | Aug 01, 2024 - Aug 05, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 49.20 |
Business WireMirum Pharmaceuticals’ LIVMARLI Data Showcased at ESPGHAN Annual Meeting
FOSTER CITY, Calif., May 18, 2024--Mirum Pharmaceuticals’ LIVMARLI Data Showcased at ESPGHAN Annual Meeting
Insider MonkeyMirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Q1 2024 Earnings Call Transcript
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Q1 2024 Earnings Call Transcript May 11, 2024 Mirum Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Hello, and welcome to the Mirum Pharmaceuticals First Quarter 2024 Financial Results and Business Update. My name […]
Business WireMirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
FOSTER CITY, Calif., May 10, 2024--Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
© 2024 Yahoo. All rights reserved.